Structural basis of the GM2 gangliosidosis B variant

被引:14
|
作者
Matsuzawa, F
Aikawa, S
Sakuraba, H
Lan, HTN
Tanaka, A
Ohno, K
Sugimoto, Y
Ninomiya, H
Doi, H
机构
[1] Celestar Lexico Sci Inc, Mihama Ku, Chiba 2618501, Japan
[2] Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci, Dept Clin Genet, Bunkyo Ku, Tokyo 1138613, Japan
[3] Osaka City Univ, Grad Sch Med, Dept Pediat, Abeno Ku, Osaka 5458585, Japan
[4] Tottori Univ, Fac Med, Sch Life Sci, Dept Pediat Neurol, Yonago, Tottori 6830826, Japan
[5] Tottori Univ, Fac Med, Sch Life Sci, Dept Neurobiol, Yonago, Tottori 6830826, Japan
关键词
GM2; gangliosidosis; Tay-Sachs disease; beta-hexosaminidase; homology modeling; ganglioside;
D O I
10.1007/s10038-003-0082-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
To study the structural basis of the GM2 gangliosidosis B variant, we constructed the three-dimensional structures of the human beta-hexosaminidase alpha-subunit and the heterodimer of the alpha- and beta-subunits, Hex A, by homology modeling. The alpha-subunit is composed of two domains, domains I and II. Nine mutant models due to specific missense mutations were constructed as well and compared with the wild type to determine structural defects. These nine mutations were divided into five groups according to structural defects. R178H is deduced to affect the active site directly, because R178 is important for binding to the substrate. C458Y and W420C are predicted to cause drastic structural changes in the barrel structure carrying the active site pocket. R504C/H is deduced to introduce a disruption of an essential binding with D494 in the beta-subunit for dimerization. R499C/H, located in an extra-helix, is deduced to disrupt hydrogen bonds with domain I and the barrel. R170W and L484P are deduced to affect the interface between domains I and II, causing destabilization. The structural defects reflect the biochemical abnormalities of the disease.
引用
收藏
页码:582 / 589
页数:8
相关论文
共 50 条
  • [1] Structural basis of the GM2 gangliosidosis B variant
    Fumiko Matsuzawa
    Sei-ichi Aikawa
    Hitoshi Sakuraba
    Hoang Thi Ngoc Lan
    Akemi Tanaka
    Kousaku Ohno
    Yuko Sugimoto
    Haruaki Ninomiya
    Hirofumi Doi
    Journal of Human Genetics, 2003, 48 : 582 - 589
  • [2] Molecular and structural studies of the GM2 gangliosidosis 0 variant
    Sakuraba, H
    Matsuzawa, F
    Aikawa, S
    Doi, H
    Kotani, M
    Lin, H
    Ohno, K
    Tanaka, A
    Yamada, H
    Uyama, E
    JOURNAL OF HUMAN GENETICS, 2002, 47 (04) : 176 - 183
  • [3] Molecular and structural studies of the GM2 gangliosidosis 0 variant
    H. Sakuraba
    F. Matsuzawa
    S. Aikawa
    H. Doi
    M. Kotani
    H. Lin
    K. Ohno
    A. Tanaka
    H. Yamada
    E. Uyama
    Journal of Human Genetics, 2002, 47 : 176 - 183
  • [4] Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis
    Deschenes, Natalie M.
    Cheng, Camilyn
    Ryckman, Alex E.
    Quinville, Brianna M.
    Khanal, Prem
    Mitchell, Melissa
    Chen, Zhilin
    Sangrar, Waheed
    Gray, Steven J.
    Walia, Jagdeep S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [5] Biochemical characterization of the GM2 gangliosidosis B1 variant
    Tutor, JC
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2004, 37 (06) : 777 - 783
  • [6] GM2 gangliosidosis variant B1 Neuroradiological findings
    Salvatore Grosso
    Maria Angela Farnetani
    Rosario Berardi
    Maria Margollicci
    Paolo Galluzzi
    Rossella Vivarelli
    Guido Morgese
    Paolo Ballestri
    Journal of Neurology, 2003, 250 : 17 - 21
  • [7] GM2 gangliosidosis variant B1 - Neuroradiological findings
    Grosso, S
    Farnetani, MA
    Berardi, R
    Margollicci, M
    Galluzzi, P
    Vivarelli, R
    Morgese, G
    Balestri, P
    JOURNAL OF NEUROLOGY, 2003, 250 (01) : 17 - 21
  • [8] GM2 Gangliosidosis in an Adult Pet Rabbit
    Rickmeyer, T.
    Schoeniger, S.
    Petermann, A.
    Harzer, K.
    Kustermann-Kuhn, B.
    Fuhrmann, H.
    Schoon, H. -A.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2013, 148 (2-3) : 243 - 247
  • [9] Genetics and Therapies for GM2 Gangliosidosis
    Cachon-Gonzalez, Maria Begoila
    Zaccariotto, Eva
    Cox, Timothy Martin
    CURRENT GENE THERAPY, 2018, 18 (02) : 68 - 89
  • [10] Rare Variant of GM2 Gangliosidosis through Activator-Protein Deficiency
    Brackmann, Florian
    Kehrer, Christiane
    Kustermann, Wibke
    Boehringer, Judith
    Kraegeloh-Mann, Ingeborg
    Trollmann, Regina
    NEUROPEDIATRICS, 2017, 48 (02) : 127 - 130